Low doses of CBD may harm some people's liver function, study warns
CBD – the non-psychoactive ingredient in cannabis that makes people feel relaxed – has become more widely available in the European Union since the bloc's high court decided in 2020 that it was not a narcotic drug, ruling that CBD 'does not appear to have any psychotropic effect or any harmful effect on human health'.
But the new findings from the US Food and Drug Administration (FDA) suggest that may not be entirely true. In a randomised controlled trial, even small amounts of CBD can affect some people's liver function.
The study included 201 healthy people in the United States, including 151 who used CBD twice per day for four weeks. The CBD doses, totalling five milligrams per day, were within the range of typical consumer products such as edibles, drinks, or lotions.
At the end of four weeks, eight of the CBD users had liver enzyme levels that were more than three times above the normal range – and seven experienced potential drug-induced liver injury.
That's compared with zero among people who did not use CBD.
Elevated liver enzymes, which can also be caused by alcohol, obesity, and some prescription medicines, can be a sign of liver inflammation or damage.
It's not clear why the eight people in the study – 5.6 per cent of those who took CBD – experienced liver problems. They did not have symptoms, and their liver enzyme levels returned to normal within two weeks of stopping CBD.
But the researchers warned that the lack of symptoms could allow liver damage to go undetected, and that people could experience more severe liver issues if they use CBD over longer periods of time or at higher doses.
Notably, there were also no differences between the two groups on endocrine hormones, for example testosterone in men.
While the study was small, it was designed so participants were randomly assigned to either take CBD or a placebo without knowing which group they were in. This kind of trial is considered the gold standard for medical research.
Even so, larger studies with more people would help to confirm the results.
The study authors said more research is needed 'on the long-term effects of CBD use, its impact on various populations, and the safety of lower doses commonly used by consumers'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
6 days ago
- Euronews
EU food safety officials set new limits on safe fluoride intake
Food safety officials have lowered the safe limit of fluoride in drinking water, though they say there is no evidence of serious health harms at levels commonly found in the European Union. Fluoride is a naturally occurring mineral that can help prevent tooth decay. Only a handful of EU countries, including Ireland and parts of Spain, add fluoride to drinking water, but it can be found in about 90 per cent of toothpastes. The World Health Organization (WHO) recommends that countries set a maximum fluoride limit at 1.5 milligrams per litre (mg/L) – the EU's legal limit – because higher levels can cause bone and teeth problems, particularly in children. But more recent studies have found that even below that level, fluoride intake may be linked to lower IQ in children. The European Food Safety Authority (EFSA) reassessed the possible risks from fluoride because of those concerns. The agency screened more than 20,000 scientific papers on fluoride's effect on the developing brain, thyroid, bones, and teeth, tracking people's exposure to fluoride in drinking water, food, fluoridated table salt, and toothpaste and other dental care products, when they are eaten or ingested. In the EU, fluoride in drinking water is usually under 0.3 mg/L, which is a safe level, EFSA said. 'We estimated that, in general, with the current concentrations of fluoride in European drinking water, total fluoride exposure … does not pose a health concern,' Susanne Hougaard Bennekou, a toxicologist and chair of EFSA's scientific committee, said in a press release. There was one exception among children ages four to eight – though the potential effects were not exactly severe. If these children regularly swallow their toothpaste, they could experience mild tooth discolouration, particularly in their developing molars. 'This is unlikely to occur if children spit the toothpaste out properly after brushing their teeth,' Bennekou said. New safety thresholds Because of this risk, EFSA set a new safe fluoride intake level at 1 milligram per day (mg/day) for babies under the age of one, 1.6 mg/day for toddlers aged one to three, and 2 mg/day for those aged four to eight. The agency said the safe limit for adults and children older than eight is 3.3 mg per day. For pregnant women, this limit would protect their developing babies against toxicity in the brain, as well as any risks of thyroid and bone problems. The new thresholds are part of a consumer risk assessment, but they could prompt a change in the EU's legal limits on fluoride in drinking water. EFSA officials said it is still not entirely clear whether fluoride poses a health threat at levels below 1.5mg/L, and called for more research on the issue. 'There is evidence that we can't ignore linking fluoride to possible effects on the developing nervous system of the foetus,' Thorhallur Halldorsson, a food science researcher and chair of EFSA's working group on fluoride, said in a statement. 'But the evidence is not sufficient to set a threshold'.
Euronews
19-07-2025
- Euronews
When is it too hot to work?
From Italy's farms to Germany's warehouses and beyond, soaring summer temperatures pose serious health risks to workers across Europe. Heat stress can cause heat exhaustion, heat stroke, and death, even hours or days later. The strain the body puts on itself trying to keep cool can also cause kidney problems and worsen heart disease, respiratory issues, and mental health. These risks came to the fore during brutal heatwaves earlier this summer, when a 51-year-old street cleaner in Barcelona collapsed and died hours after finishing her shift. Spanish authorities are investigating whether the heatwave caused her death. Unlike other environmental health hazards such as air pollution, there are no uniform rules on heat exposure for workers in the European Union, leaving member countries to make their own laws. But when is it actually too hot to work – and what can workers do to protect their health during heatwaves? Understand the risks High temperatures are not the only health risk during heatwaves. The Wet Bulb Globe Temperature (WBGT) is considered a better signal of heat stress for physically active workers because it takes into account heat, humidity, wind, and sunlight. The WBGT includes four threat levels: low, elevated, moderate, high, and extreme. Depending on the region, temperatures above 29 to 32 degrees Celsius are considered extreme threats to workers' wellbeing, raising the risk of heat illness significantly. Extreme heat is more dangerous for people working outside in physically demanding jobs, for example construction workers, agriculture workers, and emergency services. But indoor employees – including those who work in offices – can also face risks, particularly if they are in poorly cooled or ventilated buildings, according to EU-OSHA. Globally, extreme heat kills nearly 19,000 workers per year, according to the International Labour Organization (ILO), and the EU has seen a 42 per cent increase in heat-related workplace deaths since 2000. Pay attention and take action Many people may not realise they are at risk of heat stress, particularly if they are young and otherwise fit, warned Alessandro Marinaccio, research director of the occupational and environmental epidemiology unit at the nonprofit National Institute for Insurance against Accidents at Work (INAIL) in Italy. 'There is a lack of awareness about the risk for the health of workers due to occupational exposure to extreme temperature,' Marinaccio told Euronews Health. His team developed a tool to map daily risk levels for workers in Italy, depending on how physically strenuous their job is and whether they work in the sun or the shade. Health experts say workers should also pay attention to their physical symptoms. 'Workers should be mindful of elements such as dizziness, fatigue, headache, nausea, muscle cramps, fainting, and confusion,' said Ignacio Doreste, a senior advisor at the European Trade Union Confederation (ETUC), which represents labour groups. If you are feeling symptoms of heat stress, stop working, drink water, remove unnecessary clothing, and sit down in a cool, shaded area. If you cannot cool down within 30 minutes, seek emergency medical care. Know your rights Several EU countries have rules to protect workers from heat stress, including Germany, Slovenia, Hungary, Belgium, Cyprus, Greece, Spain, France, and Italy. In France, for example, employers must make fresh drinking water available to workers and adapt their workplaces and working hours to protect them from extreme heat. In parts of Italy, the government banned outdoor working during the hottest hours of the day during the last major heatwave in July. Generally, countries with heat-related laws set work limits of around 29 to 30 degrees Celsius for high-intensity work, 30 to 31 degrees for moderate work, and 31.5 to 32.5 degrees for light work, according to the ILO. The EU also mandates that employers protect workers' health and safety from occupational risks overall, though there is no specific legislation on heat stress. Across the EU, 'whenever a worker is facing a threat to his own physical integrity, they have the right not to work,' Doreste told Euronews Health. But 'enforcement is extremely needed,' he added, especially because 'diseases related to occupational heat are commonly underreported'. The ETUC has called for new laws to protect EU-based workers during heatwaves, including the right to medical examinations and the right to skip work without consequences if an employee believes working in extreme heat will put them at risk. If you are unsure about your rights during a heatwave, check your work contract or consult with your company representatives or trade union.
AFP
18-07-2025
- AFP
Health influencer falsely claims nicotine can cure neurological disorders
"Nicotine is not addictive. Parkinson's disease can be prevented and can be cured, and its symptoms reversed, with nicotine alone," health influencer Byran Ardis says in a video teasing an episode of the "Culture Apothecary" podcast from Alex Clark, a leading voice in the "Make America Healthy Again" movement. Ardis, whom AFP has previously fact-checked for spreading health misinformation, goes on to claim: "Nicotine is known by medical science to be a curative agent and a preventative agent for Alzheimer's. Did you know nicotine could also cure the symptoms of hypothyroidism?" He also asserts that "glioblastomas were proven in 2021 to be cured by nicotine alone." The clip has attracted tens of thousands of interactions on Instagram since May 19, 2025. Ardis's endorsement of nicotine patches continued to be shared across platforms in July, alongside other edits of the conversation, including one Clark posted on YouTube. Image Screenshot from Instagram taken July 18, 2025 But nicotine is an addictive chemical, and the only use for nicotine patches approved by the US Food and Drug Administration (FDA) is to quit smoking (archived here and here). "Don't use nicotine, other than trying to help quit smoking," Edward Levin, chief of the Neurobehavioral Research Lab at Duke University Medical Center, told AFP July 14 (archived here). He said the effect of nicotine on cognition, depression, Parkinson's or Alzheimer's "has not been proved, so it's still under investigation." Parkinson's disease In the podcast, Ardis claims nicotine by itself can prevent, cure or reverse symptoms of Parkinson's disease. Scientists are exploring nicotine's potential as a Parkinson's treatment due to the chemical's dopamine-increasing properties and the fact that smokers develop Parkinson's at a lower rate, but research has yielded mixed results (archived here). "Nicotine does potentially up the release of dopamine, and dopamine is what is impaired in Parkinson's disease. So the rationale for it is there, but the proof of it is not," Levin said. "To say flat out that it does prevent or cure Parkinson's just is not true." A 2015 study by the Parkinson's Institute concluded that nicotine could hold promise in terms of protecting against nerve degeneration, alleviating symptoms and reducing side effects of other drugs used to treat the disease (archived here). However, the study stops short of recommending nicotine as a proven treatment, saying instead that it "may represent a new disease modifying approach." A 2021 literature review published in Molecular Medicine Reports said nicotine may slow the progression of the disease by improving memory impairment and dyskinesia (archived here). Conversely, a trial supported by the Michael J. Fox Foundation showed nicotine patches did not slow the progression (archived here). "Despite some initially promising findings from animal models and correlational studies in humans, this has not translated well to clinical trials," Maggie Sweitzer, an associate professor in psychiatry and behavioral sciences at Duke University, told AFP in a July 15 email (archived here). "I am not aware of any solid evidence to support nicotine as a treatment in Parkinson's disease." Alzheimer's disease Ardis's second claim is that nicotine is "known by medical science" to be a curative and preventative agent for Alzheimer's disease. Researchers in the United States are currently investigating the effects of nicotine on mild cognitive impairment, a precursor to Alzheimer's, as part of the "Memory Improvement Through Nicotine Dosing" (MIND) study (archived here). But nicotine has not been incorporated into human treatment beyond clinical trials. A 2012 trial focused on 67 subjects concluded that nicotine led to cognitive improvement in attention, memory and processing, but it said further study would be necessary to determine if the findings were clinically important (archived here). A much larger follow-up is currently in progress, with results expected later in 2025 (archived here). Levin, a researcher on the MIND study, said despite promising findings, nicotine patches have not yet been FDA approved to protect against cognitive decline. "I can't recommend it," Levin said. "It's not FDA approved for that purpose. It's under investigation." Levin said that if nicotine patches were implemented as a treatment for Alzheimer's or other cognitive diseases, they would likely be used alongside other drugs, rather than alone. He also pushed back on Ardis's claim that it is safe to place nicotine patches on children, saying the drug is toxic from early fetal development through adolescence and can adversely impact the nervous system (archived here). Glioblastoma Ardis then claims nicotine alone was proven in 2021 to cure glioblastoma, an aggressive form of brain cancer. AFP did not find a reference with such clear proof. Instead, a 2021 paper in Pharmacological Research showed nicotine can promote the proliferation of glioblastoma cells, with nicotinic receptors potentially contributing to the tumor's aggressive behavior (archived here). The paper also discovered that drugs that block nicotinic receptors can decrease glioblastoma cell growth. An earlier literature review said smoking and other uses of tobacco and nicotine during treatment can detrimentally affect a patient's prognosis (archived here). Keyword searches did reveal a 2022 in vivo study which found that nicotine, in conjunction with lithium carbonate, can suppress and kill glioblastoma cells, although the study also warns of health risks resulting from nicotine's cytotoxicity (archived here). But such findings have not been replicated outside of in vivo cell studies, and Sweitzer said it would be difficult to study the isolated effect of nicotine on glioblastoma in a clinical setting. "It would be unethical for researchers to assign patients with glioblastomas to a treatment condition where they received 'nicotine alone' in the absence of usual standard of care, because this would deprive the patients of treatment that they would receive if they were not in the study," Sweitzer said. "In general, people should be highly skeptical about claims that something has been 'proven' in health and medicine." Lead Stories and Medical Dialogues previously debunked claims by Ardis that nicotine can cure brain tumors in as little as 72 hours. Hypothyroidism Finally, Ardis poses that nicotine could cure symptoms of hypothyroidism, a thyroid gland condition that can lead to high cholesterol and heart problems. The 2021 Molecular Medicine Reports literature review said nicotine may "activate thyroid receptor signaling pathways" to improve hypothyroidism-induced memory impairment (archived here). But Sweitzer said Ardis's claim misleads. "There are interactions between nicotine and thyroid hormones that have been clearly demonstrated in animal models," Sweitzer said (archived here and here). "But I am not aware of any evidence that would suggest nicotine can be used as a treatment in itself." Rexford Ahima, director of the division of endocrinology, diabetes and metabolism at Johns Hopkins University, agreed (archived here). "Nicotine does not cure hypothyroidism," Ahima told AFP in a July 15 email. "Nicotine use, especially through smoking, is linked to worsening of autoimmune hyperthyroidism." AFP has debunked other health misinformation here.
